Eupraxia Pharmaceuticals Inc
(EPRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 6,555 | 6,694 | 12,177 | 6,623 | 5,710 |
| Operating Income | -6,555 | -6,694 | -12,177 | -6,623 | -5,710 |
| Interest Expense | 282 | 321 | 257 | 321 | 302 |
| Other Income | 768 | 863 | 1,862 | 2,047 | -3,495 |
| Pre-tax Income | -6,069 | -6,152 | -10,572 | -4,896 | -9,506 |
| Income Tax | 5 | 5 | 36 | N/A | N/A |
| Net Income Continuous | -6,074 | -6,157 | -4,096 | -4,896 | -9,506 |
| Minority Interests | -57 | -114 | -380 | -175 | -129 |
| Net Income | $-6,007 | $-6,043 | $-4,096 | $-4,721 | $-9,377 |
| EPS Basic Total Ops | -0.17 | -0.21 | -0.17 | -0.18 | -0.43 |
| EPS Basic Continuous Ops | -0.17 | -0.21 | -0.17 | -0.19 | -0.43 |
| EPS Diluted Total Ops | -0.17 | -0.21 | -0.17 | -0.18 | -0.43 |
| EPS Diluted Continuous Ops | -0.17 | -0.21 | -0.17 | -0.19 | -0.43 |
| EPS Diluted Before Non-Recurring Items | -0.17 | -0.21 | -0.17 | N/A | N/A |
| EBITDA(a) | $-6,513 | $-6,656 | $-12,136 | $-6,584 | $-5,672 |